* Immuno-oncology World Congress (updated 2024-11-27) ~ youtor.org

Immuno-oncology World Congress (updated 2024-11-27)

Ovarian cancer at ESMO 2024 PRIMA and ATHENA [upl. by Ardnassak]

Ovarian cancer at ESMO 2024 PRIMA and ATHENA

Duration: 0:34
46 views | 1 month ago

Unanswered questions in aggressive Bcell lymphoma [upl. by Ermentrude]

Unanswered questions in aggressive Bcell lymphoma

Duration: 3:23
19 views | 1 month ago

Combination immunotherapy strategies in colorectal cancer [upl. by Amorita713]

Combination immunotherapy strategies in colorectal cancer

Duration: 0:23
181 views | 4 months ago

A study comparing infection rates in patients treated with BCMA versus CD19directed CARTs [upl. by Stockwell]

A study comparing infection rates in patients treated with BCMA versus CD19directed CARTs

Duration: 2:29
84 views | 1 month ago

The emerging role of checkpoint inhibitors in liver cancer [upl. by Subak570]

The emerging role of checkpoint inhibitors in liver cancer

Duration: 1:19
57 views | 4 months ago

Selecting and sequencing therapies for RR multiple myeloma [upl. by Leunas]

Selecting and sequencing therapies for RR multiple myeloma

Duration: 1:38
39 views | 1 month ago

Advances in Hodgkin lymphoma treatment moving away from ABVD and BEACOPP [upl. by Eniale661]

Advances in Hodgkin lymphoma treatment moving away from ABVD and BEACOPP

Duration: 1:47
40 views | 1 month ago

Factors to consider when selecting patients with multiple myeloma for treatment with bispecifics [upl. by Bobina]

Factors to consider when selecting patients with multiple myeloma for treatment with bispecifics

Duration: 0:42
31 views | 1 month ago

Identifying highrisk DLBCL and optimizing treatment for these patients [upl. by Ruffin]

Identifying highrisk DLBCL and optimizing treatment for these patients

Duration: 1:05
87 views | 2 months ago

Intracranial CD1cCD141 myeloid dendritic cells with ipilimumab amp nivolumab in highgrade glioma [upl. by Trelu]

Intracranial CD1cCD141 myeloid dendritic cells with ipilimumab amp nivolumab in highgrade glioma

Duration: 2:48
93 views | 2 months ago

A trial investigating IberVd in transplantineligible newly diagnosed multiple myeloma [upl. by Eislel430]

A trial investigating IberVd in transplantineligible newly diagnosed multiple myeloma

Duration: 1:10
2 views | 1 month ago

Promising future for cholangiocarcinoma diagnosis and treatment [upl. by Engleman]

Promising future for cholangiocarcinoma diagnosis and treatment

Duration: 2:11
418 views | 7 Jul 2022

Preventing and managing infections in patients with lymphoma treated with immunosuppressive therapy [upl. by Birck718]

Preventing and managing infections in patients with lymphoma treated with immunosuppressive therapy

Duration: 1:18
51 views | 2 months ago

Incidence and risk factors associated with VODSOS in younger vs older adults after SCT [upl. by Dwight401]

Incidence and risk factors associated with VODSOS in younger vs older adults after SCT

Duration: 1:26
1 views | 1 month ago

Treatments for HER2 esophagogastric cancer [upl. by Aleydis]

Treatments for HER2 esophagogastric cancer

Duration: 2:15
90 views | 13 Jul 2022

Sequencing immunotherapies in multiple myeloma [upl. by Enyar]

Sequencing immunotherapies in multiple myeloma

Duration: 1:57
64 views | 5 months ago

Cardiac biomarkers for immune checkpoint inhibitorrelated myocarditis in cancer patients [upl. by Shargel]

Cardiac biomarkers for immune checkpoint inhibitorrelated myocarditis in cancer patients

Duration: 2:15
133 views | 6 months ago

Novel treatment options for TKIresistant gastrointestinal stromal tumors [upl. by Orth]

Novel treatment options for TKIresistant gastrointestinal stromal tumors

Duration: 1:16
26 views | 1 month ago

Managing patients with multiple myeloma who have failed CART therapy [upl. by Erodasi988]

Managing patients with multiple myeloma who have failed CART therapy

Duration: 1:12
175 views | 2 months ago

Highlights from a CLL session BTKis personalizing care novel regimens amp more [upl. by Stan]

Highlights from a CLL session BTKis personalizing care novel regimens amp more

Duration: 3:17
59 views | 1 month ago

The sensitization of immune checkpoint inhibitors with subsequent chemotherapy in RR HL [upl. by Ylrehs999]

The sensitization of immune checkpoint inhibitors with subsequent chemotherapy in RR HL

Duration: 1:10
69 views | 4 months ago

Overcoming ontarget offtumor toxicity in AML current challenges and potential solutions [upl. by Balch]

Overcoming ontarget offtumor toxicity in AML current challenges and potential solutions

Duration: 1:45
88 views | 2 months ago

Being more selective when choosing myeloma candidates for CART therapy due to capacity issues [upl. by Kariv416]

Being more selective when choosing myeloma candidates for CART therapy due to capacity issues

Duration: 1:27
1 views | 2 months ago

The future of antibodydrug conjugates in endometrial cancer [upl. by Pals50]

The future of antibodydrug conjugates in endometrial cancer

Duration: 1:43
58 views | 1 month ago

Safety and efficacy of inotuzumab ozogamicin conditioning for alloSCT in lymphoid malignancies [upl. by Adriaens443]

Safety and efficacy of inotuzumab ozogamicin conditioning for alloSCT in lymphoid malignancies

Duration: 2:45
63 views | 1 month ago

The need for novel agents to treat patients with MCL who have relapsed after targeted therapy [upl. by Gosser]

The need for novel agents to treat patients with MCL who have relapsed after targeted therapy

Duration: 2:22
166 views | 1 month ago

Minimizing immunotherapyinduced toxicity in patients with GI tumors [upl. by Ruhtracm582]

Minimizing immunotherapyinduced toxicity in patients with GI tumors

Duration: 0:38
107 views | 4 months ago

Evaluating realworld efficacy of durvalumab and tremelimumab in HCC [upl. by Dever]

Evaluating realworld efficacy of durvalumab and tremelimumab in HCC

Duration: 1:02
105 views | 4 months ago

Enhancing treatment outcomes in RCC and NSCLC with Akkermansia supplements [upl. by Andaira]

Enhancing treatment outcomes in RCC and NSCLC with Akkermansia supplements

Duration: 0:59
21 views | 1 month ago

5year followup of EV and pembrolizumab for lamUC in the EV103 trial [upl. by Lajes]

5year followup of EV and pembrolizumab for lamUC in the EV103 trial

Duration: 1:30
53 views | 1 month ago

Our site allows you to download your favorite videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024